SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-004103
Filing Date
2013-01-25
Accepted
2013-01-25 18:11:23
Documents
1
Period of Report
2013-01-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v333066_4.html 4  
1 OWNERSHIP DOCUMENT v333066_4.xml 4 4535
  Complete submission text file 0001144204-13-004103.txt   6229
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854
Business Address
Conover Charles (Reporting) CIK: 0001538563 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 13549817